Formerly doing business as Sterling Point Research LL, in 2010 two aerospace engineers and a physician turned biomedical engineer realized that -- especially in the ICU (Intensive Care) -- the deluge of physiologic patient data experienced by doctors detracted from effective patient care. Their judgment was that the sheer volume and complexity of data could be overwhelming and - when combined with the high stress/high stakes environment of intensive care - could lead to patient harm and clinicians burnout. Etiometry was founded to apply aerospace- based predictive analytics methodology to physiologic data ... harvesting the power of technology to optimize clinical decisions and improve patient outcomes. The proprietary technology that is the Etiometry Platform is an FDA cleared next-generation patient monitoring Software Platform designed to assist medical personnel by interpreting large volumes of real time data and providing a snapshot view of the clinical risks to the patient - providing intensive care units with actionable timely information - synthesizing all physiologic data into specific patient risks, the platform raises the situational awareness of the whole clinical team - allowing them to intervene early and avoid patient harm. With several quality pediatric hospitals as clients, the firm's platform has been associated with a siginificant reduction of patient length of stay with the consequent reducion in ICU expenditures. The availability of aggregated data has given rise to an opportunity for next generation analytics. Spearheaded with clinical partners, Etiometrys comprehensive technology is supporting a shift from signal based patient monitoring to risk based patient monitoring
